Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Aug 21;2014(8):CD008945.
doi: 10.1002/14651858.CD008945.pub2.

Antioxidants for pain in chronic pancreatitis

Usama Ahmed Ali  1 , Sjoerd Jens, Olivier R C Busch, Frederik Keus, Harry van Goor, Hein G Gooszen, Marja A Boermeester
Affiliations
Meta-Analysis

Antioxidants for pain in chronic pancreatitis

Usama Ahmed Ali et al. Cochrane Database Syst Rev. .

Abstract

Background: Reduced intake and absorption of antioxidants due to pain and malabsorption are probable causes of the lower levels of antioxidants observed in patients with chronic pancreatitis (CP). Improving the status of antioxidants might be effective in slowing the disease process and reducing pain in CP.

Objectives: To assess the benefits and harms of antioxidants for the treatment of pain in patients with CP.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and the Conference Proceedings Citation Index from inception to October 2012. Two review authors performed the selection of trials independently.

Selection criteria: We included all randomised controlled trials (RCTs) evaluating antioxidants for treatment of pain in CP. All trials were included irrespective of blinding, numbers of participants randomly assigned and language of the article.

Data collection and analysis: Two review authors extracted data independently. The risk of bias of included trials was assessed. Study authors were asked for additional information in the case of missing data.

Main results: Twelve RCTs with a total of 585 participants were included. Six trials were double-blinded, placebo-controlled studies, and the other six trials were of less adequate methodology. Most trials were small and had high rates of dropout. Eleven of the 12 included trials described the effects of antioxidants on chronic abdominal pain in chronic pancreatitis. Pain as measured on a visual analogue scale (VAS, scale range 0 to 10) after one to six months was less in the antioxidant group than in the control group (mean difference (MD) -0.33, 95% confidence interval (CI) -0.64 to -0.02, P value 0.04, moderate-quality evidence). The number of pain-free participants was not statistically significantly different (risk ratio (RR) 1.73, 95% CI 0.95 to 3.15, P value 0.07, low-quality evidence). More adverse events were observed in the antioxidant group, both in the parallel trials (RR 4.43, 95% CI 1.60 to 12.29, P value 0.0004, moderate-quality evidence) and in the cross-over trials (RR 5.80, 95% CI 1.56 to 21.53, P value 0.0009, moderate-quality evidence). Adverse events occurred in 16% of participants and were mostly mild (e.g. headache, gastrointestinal complaints), but were sufficient to make participants stop antioxidant use. Other important outcomes such as use of analgesics, exacerbation of pancreatitis and quality of life were rarely reported. One trial from 1991 evaluated the effects of antioxidants on acute pain during exacerbation of chronic pancreatitis and found that a significantly higher proportion of participants in the antioxidant group experienced pain relief. This trial was conducted more than 25 years ago and has not been reproduced since that time. Therefore, additional trials are needed before reliable conclusions can be drawn.

Authors' conclusions: Current evidence shows that antioxidants can reduce pain slightly in patients with chronic pancreatitis. The clinical relevance of this small reduction is uncertain, and more evidence is needed. Adverse events in one of six patients may prevent the use of antioxidants. Effects of antioxidants on other outcome measures, such as use of analgesics, exacerbation of pancreatitis and quality of life remain uncertain because reliable data are not available.

PubMed Disclaimer

Conflict of interest statement

Authors have reported no conflicts of interest.

Figures

1
1
Summary of risk of bias: review authors' judgements about each risk of bias domain for included trials.
2
2
Study flow diagram.
3
3
Evaluation of publication bias by funnel plot (based on the outcome 'adverse effects').
1.1
1.1. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 1 Pain visual analogue scale score—cross‐over trials.
1.2
1.2. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 2 Pain visual analogue scale score—parallel trials.
1.3
1.3. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 3 Pain visual analogue scale score—combined all trials.
1.4
1.4. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 4 Pain‐free participants—parallel trials.
1.5
1.5. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 5 Adverse effects.
1.6
1.6. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 6 Adverse effects—sensitivity analysis of parallel and cross‐over trials.
1.7
1.7. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 7 Adverse effects—sensitivity analysis with risk difference.
1.8
1.8. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 8 Number of pancreatitis attacks—cross‐over trials, unpaired analysis.
1.9
1.9. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 9 Vitamin C levels (mg/dL)—parallel trials.
1.10
1.10. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 10 Vitamin C levels (mg/dL)—sensitivity analysis of parallel and cross‐over trials.
1.11
1.11. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 11 Vitamin E levels (mg/dL)—parallel trials.
1.12
1.12. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 12 Vitamin E levels (mg/dL)—sensitivity analysis of parallel and cross‐over trials.
1.13
1.13. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 13 Selenium levels (μg/dL)—sensitivity analysis of parallel and cross‐over trials.
1.14
1.14. Analysis
Comparison 1 Antioxidant versus control intervention, Outcome 14 β‐Carotene levels (μg/dL)—sensitivity analysis of parallel and cross‐over trials.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Banks 1997 {published data only}
    1. Banks PA, Hughes M, Ferrante M, Noordhoek EC, Ramagopal V, Slivka A. Does allopurinol reduce pain of chronic pancreatitis?. International Journal of Pancreatology 1997;22(3):171‐6. - PubMed
Bhardwaj 2009 {published data only}
    1. Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009;136(1):149‐59. - PubMed
    1. Bhardwaj P, Garg PK, Saraya A, Acharya S. Antioxidant supplementation for pain relief in chronic pancreatitis: a randomized placebo controlled double blind trial. Gastroenterology 2007;132:A51. - PubMed
    1. Bhardwaj PG. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009;136:abstract. - PubMed
Bilton 1994a {published data only}
    1. Bilton D, Schofield D, Mei G, Kay PM, Bottiglieri T, Braganza JM. Placebo‐controlled trials of antioxidant therapy including S‐adenosylmethionine in patients with recurrent non‐gallstone pancreatitis. Clinical Drug Investigation 1994;8:10‐20.
Bilton 1994b {published data only}
    1. Bilton D, Schofield D, Mei G, Kay PM, Bottiglieri T, Braganza JM. Placebo‐controlled trials of antioxidant therapy including S‐adenosylmethionine in patients with recurrent non‐gallstone pancreatitis. Clinical Drug Investigation 1994;8:10‐20.
Deprez 2003 {published data only}
    1. Deprez PH, Delazzer E, Galanti L, Lebrun J, Geubel A, Horsmans Y. Clinical and nutritional effects of anti‐oxidant supplementation: a prospective randomized study in patients with chronic pancreatitis. Gastroenterology 2003;124(4):A90.
Durgaprasad 2005 {published data only}
    1. Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian Journal of Medical Research 2005;122(4):315‐8. - PubMed
Jarosz 2010 {published data only}
    1. Jarosz M, Orzeszko M, Rychlik E, Kozuch M. Antioxidants in the treatment of chronic pancreatis [Antyoksydanty w leczeniu przewlekłego zapalenia trzustki]. Gastroenterologia Polska 2010;17:41‐6.
Kirk 2006 {published data only}
    1. Kirk GR, White JS, McKie L, Stevenson M, Young I, Clements WD, Rowlands BJ. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. Journal of Gastrointestinal Surgery 2006;10(4):499‐503. - PubMed
Nandi 2002 {published data only}
    1. Nandi B, Garg PK, Bhardwaj P, Prakash S, Tandon RK. Efficacy of antioxidants for pain relief in patients with chronic pancreatitis: a randomized controlled trial. Indian Journal of Gastroenterology 2002;21(Suppl 1):A43. - PubMed
Salim 1991 {published data only}
    1. Salim AS. Role of oxygen‐derived free radical scavengers in the treatment of recurrent pain produced by chronic pancreatitis. A new approach.. Archives of Surgery 1991;9:1109‐14. - PubMed
Siriwardena 2012 {published data only}
    1. Shah N, Mason JM, Makin AJ, Sheen AJ, Siriwardena AK. A randomised, double‐blind, placebo‐controlled trial of oral antioxidant therapy for chronic pancreatitis: the final results of the ANTICIPATE study. British Journal of Surgery 2012;99:2.
    1. Siriwardena A, Mason J, Sheen A, Makin A, Shah N. Antioxidant therapy for chronic pancreatitis: the final results of a randomised, double blind, placebo‐controlled trial (the ANTICIPATE STUDY). HPB 2012;14:663.
    1. Siriwardena AK, Mason JM, Shah NS, Sheen AJ. Antioxidant therapy for chronic pancreatitis: a randomized, controlled trial. Gastroenterology 2012;142:S113. - PubMed
    1. Siriwardena AK, Mason JM, Sheen AJ, Makin AJ, Shah NS. Antioxidant therapy does not reduce pain in patients with chronic pancreatitis: the ANTICIPATE study. Gastroenterology 2012;143:655–63. - PubMed
Uden 1990 {published data only}
    1. Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo‐controlled trial. Alimentary Pharmacology & Therapeutics 1990;4(4):357‐71. - PubMed
    1. Uden S, Main C. Placebo‐controlled double‐blind trial of antioxidant supplements in patients with recurrent pancreatitis. Clinical Science 1989;77(Suppl 21):26P‐27P.
    1. Uden S, Schofield D, Miller PF, Day JP, Bottiglier T, Braganza JM. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo‐controlled trial. Alimentary Pharmacology & Therapeutics 1992;6(2):229‐40. - PubMed

References to studies excluded from this review

Bagul 2006 {published data only}
    1. Bagul A, Siriwardena AK. Long‐term outcome of oral anti‐oxidant therapy in patients with painful chronic pancreatitis. Gastroenterology 2006;130(4):A517.
Bhardwaj 2004 {published data only}
    1. Bhardwaj P, Thareja S, Prakash S, Saraya A, Bhardwaj P, Thareja S, et al. Micronutrient antioxidant intake in patients with chronic pancreatitis. Tropical Gastroenterology 2004;25:69‐72. - PubMed
Bhardwaj 2006 {published data only}
    1. Bhardwaj P, Garg PK, Saraya A. Free radical mediated oxidative stress and antioxidant status in patients with chronic pancreatitis. Free Radical Research 2006;40:S107.
Braganza 1991 {published data only}
    1. Braganza JM. Antioxidant therapy for pancreatitis—clinical experience. Pathogenesis of Pancreatitis. Manchester, UK: Manchester University Press, 1991:178‐97.
De las Heras 2000 {published data only}
    1. las Heras CG, Garcia de la Paz A, Fernandez MD, Fernandez‐Forcelledo JL. Use of antioxidants to treat pain in chronic pancreatitis. Revista Espanola de Enfermedades Digestivas 2000;92:375‐85. - PubMed
Klapdor 2012 {published data only}
    1. Klapdor S, Richter E, Klapdor R. Vitamin D status and per‐oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Research 2012;32:1991‐8. - PubMed
Martinez‐Torres 2009 {published data only}
    1. Martinez‐Torres HR‐L. Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography. World Journal of Gastroenterology 2009;15:7. - PMC - PubMed
Matthew 1996 {published data only}
    1. Mathew P, Wyllie R, Van LF, Steffen RM, Kay MH, Mathew P, et al. Antioxidants in hereditary pancreatitis. American Journal of Gastroenterology 1996;91:1558‐62. - PubMed
Milnerowicz 2005 {published data only}
    1. Milnerowicz H, Jablonowska M, Milnerowicz S. The level of GSH and antioxidant enzyme activity: GPx and Cu/Zn SOD in patients with pancreatitis. FEBS Journal 2005;272:427.
Mosler 2005 {published data only}
    1. Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, et al. Does prophylactic allopurinol administration reduce the risk and severity of post‐ERCP pancreatitis: randomized prospective multicenter study. Gastrointestinal Endoscopy 2005;61:AB100. - PubMed
Nakamura 1996 {published data only}
    1. Nakamura T, Takebe K, Imamura K, Tando Y, Yamada N, Arai Y, et al. Fat‐soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). Acta Gastro‐enterologica Belgica 1996;59:10‐4. - PubMed
Romagnuolo 2008 {published data only}
    1. Romagnuolo J, Hilsden R, Sandha GS, Cole M, Bass S, May G, et al. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo‐controlled trial. Clinical Gastroenterology and Hepatology 2008;6:465‐71. - PubMed
    1. Romagnuolo J, Hilsden RJ, Sandha GS, Cole MJ, Bass S, May GR, et al. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP): a randomized placebo‐controlled trial. Gastrointestinal Endoscopy 2008;67:AB328. - PubMed
    1. Romagnuolo J, Sandha G, Kruger C, May G, Cole N, Bass S, et al. Allopurinol to prevent post‐ERCP pancreatitis: blind interim analysis of a randomized placebo‐controlled trial. Gastrointestinal Endoscopy 2005;61:AB195.
Shah 2010 {published data only}
    1. Shah NS, Makin AJ, Sheen AJ, Siriwardena AK. Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World Journal of Gastroenterology 2010;16:4066‐71. - PMC - PubMed
Shalimar 2011 {published data only}
    1. Shalimar S, Midha S, Bhardwaj P, Garg PK. Long‐term pain relief with optimized medical therapy including antioxidants in patients with chronic pancreatitis. Gastroenterology 2011;140:S547. - PubMed
Sinwardena 2006 {published data only}
    1. Sinwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, et al. Randomized, double‐blind, placebo‐controlled, trial of high‐dose intravenous anti‐oxidant therapy in severe acute pancreatitis. Gastroenterology 2006;130:A83.
Uden 1988 {published data only}
    1. Uden S, Acheson DW, Reeves J, Worthington HV, Hunt LP, Brown S, et al. Antioxidants, enzyme induction, and chronic pancreatitis: a reappraisal following studies in patients on anticonvulsants. European Journal of Clinical Nutrition 1988;42:561‐9. - PubMed

References to ongoing studies

EUROPAC‐2 {published data only}
    1. EUROPAC‐2.‐ Pain Treatment of Hereditary and Idiopathic Pancreatitis. Clinicaltrials.gov.

Additional references

Apte 1999
    1. Apte MV, Keogh GW, Wilson JS. Chronic pancreatitis: complications and management. Journal of Clinical Gastroenterology 1999;29(3):225‐40. - PubMed
Begg 1994
    1. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088‐101. [PUBMED: 7786990] - PubMed
Bjelakovic 2008
    1. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD004183.pub3] - DOI - PMC - PubMed
Bowrey 1999
    1. Bowrey DJ, Morris‐Stiff GJ, Puntis MC. Selenium deficiency and chronic pancreatitis: disease mechanism and potential for therapy. HPB Surgery 1999;11(4):207‐15. - PMC - PubMed
Braganza 2010
    1. Braganza JM, Dormandy TL. Micronutrient therapy for chronic pancreatitis: rationale and impact. Journal of the Pancreas 2010;11(2):99‐112. - PubMed
Curtin 2002
    1. Curtin F, Elbourne D, Altman DG. Meta‐analysis combining parallel and cross‐over clinical trials. II: Binary outcomes. Statistics in Medicine 2002;21(15):2145‐59. - PubMed
Dite 2001
    1. Dite P, Stary K, Novotny I, Precechtelova M, Dolina J, Lata J, Zboril V. Incidence of chronic pancreatitis in the Czech Republic. The European Journal of Gastroenterology and Hepatology 2001;13:749‐50. - PubMed
Egger 1997
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34. - PMC - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9. - PubMed
Feng 2010
    1. Feng Z, Liu Z, Li X, Jia H, Sun L, Tian C, et al. Alpha‐tocopherol is an effective phase II enzyme inducer: protective effects on acrolein‐induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. The Journal of Nutritional Biochemistry 2010;21(12):1222‐31. - PubMed
Gachago 2008
    1. Gachago C, Draganov PV. Pain management in chronic pancreatitis. World Journal of Gastroenterology 2008;14(20):3137‐48. - PMC - PubMed
Guyan 1990
    1. Guyan PM, Uden S, Braganza JM. Heightened free radical activity in pancreatitis. Free Radical Biology and Medicine 1990;8(4):347‐54. - PubMed
Hawker 2011
    1. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care and Research 2011;63(Suppl 11):S240‐52. - PubMed
Higgins 2002
    1. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21:1539‐58. - PubMed
Higgins 2008
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions. New York: John Wiley & Sons Ltd, 2008.
Higgins 2008a
    1. Higgins JPT, Green S. Section 16.4.3. Assessing risk of bias in cross‐over trials. Cochrane Handbook for Systematic Reviews of Interventions. New York: John Wiley & Sons Ltd, 2008.
Hozo 2005
    1. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5(1):13. - PMC - PubMed
Kalvaria 1986
    1. Kalvaria I, Labadarios D, Shephard GS, Visser L, Marks IN. Biochemical vitamin E deficiency in chronic pancreatitis. International Journal of Pancreatology 1986;1(2):119‐28. - PubMed
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomised trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9. - PubMed
Levy 2006
    1. Levy P, Barthet M, Mollard BR, Amouretti M, Marion‐Audibert AM, Dyard F. Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterology Clinical Biology 2006;30:838‐44. - PubMed
Macaskill 2001
    1. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine 2001;20:641‐54. - PubMed
McGee 2011
    1. McGee RG, Su M, Kelly PJ, Higgins GY, Craig JC, Webster AC. Trial registration and declaration of registration by authors of randomized controlled trials. Transplantation 2011;92(10):1094‐100. - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13. - PubMed
Monfared 2009
    1. Monfared SSMS, Vahidi H, Abdolghaffari AH, Nikfar S, Abdollahi M. Antioxidant therapy in the management of acute, chronic and post‐ERCP pancreatitis: a systematic review. World Journal of Gastroenterology 2009;15(36):4481‐90. - PMC - PubMed
Owen 2000
    1. Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H. The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. European Journal of Cancer 2000;36(10):1235‐47. - PubMed
Pezzilli 2005
    1. Pezzilli R, Morselli Labate AM, Ceciliato R, Frulloni L, Cavestro GM, Comparato G, et al. Quality of life in patients with chronic pancreatitis. Digestive Liver Disease 2005;37:181‐9. - PubMed
Ramos‐Márquez 2008
    1. Ramos‐Márquez ME, Siller‐López F. Current antioxidant molecular therapies for oxidative stress–related ailments. Current Gene Therapy 2008;8(4):256‐63. - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rose 1986
    1. Rose P, Fraine E, Hunt LP, Acheson DW, Braganza JM. Dietary antioxidants and chronic pancreatitis. Human Nutrition ‐ Clinical Nutrition 1986;40(2):151‐64. - PubMed
Sala 2002
    1. Sala A, Recio MD, Giner RM, Manez S, Tournier H, Schinella G, et al. Anti‐inflammatory and antioxidant properties of Helichrysum italicum. The Journal of Pharmacy and Pharmacology 2002;54(3):365‐71. - PubMed
Schneider 2007
    1. Schneider A, Lohr JM, Singer MV. The M‐ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. Journal of Gastroenterology 2007;42(2):101‐19. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayer R, Altman D. Empirical evidence of bias. JAMA 1995;273(5):408‐12. - PubMed
Spanier 2008
    1. Spanier BW, Dijkgraaf MG, Bruno MJ. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: an update. Best Practice and Research. Clinical Gastroenterology 2008;22:45‐63. - PubMed
Stedman 2011
    1. Stedman MR, Curtin F, Elbourne DR, Kesselheim AS, Brookhart MA. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2011;40(6):1732‐4. - PubMed
Temple 2000
    1. Temple NJ. Antioxidants and disease: more questions than answers. Nutrition Research 2000;20(3):449‐59.
van Esch 2006
    1. Esch AA, Wilder‐Smith OH, Jansen JB, Goor H, Drenth JP. Pharmacological management of pain in chronic pancreatitis. Digestive Liver Disease 2006;38(7):518‐26. - PubMed
Wehler 2004
    1. Wehler M, Nichterlein R, Fischer B, Farnbacher M, Reulbach U, Hahn EG, et al. Factors associated with health‐related quality of life in chronic pancreatitis. American Journal of Gastroenterology 2004;99:138‐46. - PubMed
Willett 2002
    1. Willett WC. Balancing life‐style and genomics research for disease prevention. Science 2002;296:695‐8. - PubMed
Witt 2007
    1. Witt H, Apte MV, Keim V, Wilson JS. Chronic pancreatitis: challenges and advances in the pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007;132(4):1557‐73. - PubMed